Filter
801
Text search:
rifampicin
Featured
Recommendations
111
New Publications
241
Language
Document type
No document type
566
Guidelines
104
Studies & Reports
61
Manuals
28
Fact sheets
13
Strategic & Response Plan
12
Training Material
9
Situation Updates
4
Infographics
2
App
1
Resource Platforms
1
Countries / Regions
India
57
Western and Central Europe
56
Eastern Europe
32
Nepal
23
South Africa
23
Kenya
19
Tanzania
16
Nigeria
14
Germany
13
Namibia
13
Ethiopia
12
Uganda
12
Zambia
12
Bangladesh
12
Global
11
Malawi
10
Philippines
9
Cambodia
9
Myanmar / Burma
9
South–East Asia Region
9
Latin America and the Carribbean
9
Ukraine
8
Rwanda
7
Asia
7
Russia
6
Eswatini/ Swaziland
5
Africa
5
Tajikistan
5
Indonesia
4
Botswana
4
Sierra Leone
3
Ghana
3
Zimbabwe
3
Pakistan
3
Mozambique
3
Argentina
3
Colombia
3
Lesotho
3
Bhutan
3
Georgia
3
Liberia
2
Senegal
2
Syria
2
Benin
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Armenia
2
Timor Leste/ East Timor
2
Burkina Faso
1
Congo, Democratic Republic of
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Malaysia
1
Sudan
1
Brazil
1
North Macedonia
1
Switzerland
1
Serbia
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Solomon Islands
1
North Korea
1
Albania
1
Laos
1
Romania
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Uruguay
1
Turkmenistan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
109
Public Health
18
Women & Child Health
18
Capacity Building
16
Pharmacy & Technologies
12
Key Resources
5
Toolboxes
TB
352
HIV
75
NTDs
39
AMR
27
Pharmacy
26
Refugee
15
Polio
10
Ebola
5
Caregiver
5
Conflict
4
COVID-19
4
Mental Health
3
Global Health Education
3
Rapid Response
2
Natural Hazards
1
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim
...
Глобальными приоритетами для лечения туберкулеза (ТБ) и борьбы с ним являются улучшенное и ранее выявление случаев туберкулеза, в том числе случаев заболевания с о
...
Journal of Infectious Diseases and Therapeutics, 2013, 1, 17-24
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection.
...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral
...
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral
...
This study consists of a descriptive analysis of M. tuberculosis isolates from Beira Central Hospital, Mozambique, during 2014–2015, being the first report of a genotypic testing used to provide information about second line drug resistance in Mozambique.
BMC Infectious Diseases (2016) 16:423 DO
...
Uganda: Management of Tuberculosis in Children
recommended
A health worker guide.
The objective of the study was the validation and implementation of GeneXpert MTB/RIF for routine use in the rapid detection of tuberculosis and sensitivity to rifampicin in clinical samples; for this, 1592 respiratory samples were collected and ana
...
Research to develop point-of-care tests is in progress. Treatment of Buruli ulcer comprises 8 weeks of combined antibiotics (rifampicin and clarithromycin). Complementary therapies such as wound care, skin graft and prevention of disability are need
...
